Snowball will help you to track your portfolio, plan deposits to your brokerage account and support your passive income strategy with tools and community of investors
What sector does Cosmos Pharmaceutical Corp (3349) operate in?
Cosmos Pharmaceutical Corp belongs to the Consumer Staples sector and operates in the Pharmaceutical Retailers industry.
What is Cosmos Pharmaceutical Corp (3349) current stock price?
As of the latest data, Cosmos Pharmaceutical Corp stock price is ¥8,880, with a previous close of ¥9,053. Cosmos Pharmaceutical Corp lost -¥173 in the last trading session, representing a -1.91% loss.
What is Cosmos Pharmaceutical Corp (3349) current market capitalization?
Cosmos Pharmaceutical Corp market cap is approximately 703.80 billion.
What is Cosmos Pharmaceutical Corp (3349) Earnings Per Share (EPS)?
The trailing EPS is ¥391.
What is Cosmos Pharmaceutical Corp (3349) Price-to-Earnings (P/E) ratio?
Cosmos Pharmaceutical Corp current P/E ratio is 22.7.
What is Cosmos Pharmaceutical Corp (3349) EBITDA?
Cosmos Pharmaceutical Corp EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 15.31 billion.
Does Cosmos Pharmaceutical Corp (3349) pay dividends?
Yes. Cosmos Pharmaceutical Corp pays semiannual dividends with an annualized yield of 0.84% and an estimated annual payout of ¥75 per share.
When is the next ex-dividend date for Cosmos Pharmaceutical Corp (3349)?
The next ex-dividend date is scheduled for November 29, 2025.
How did Cosmos Pharmaceutical Corp (3349) perform in its most recent earnings report?
In the last report (May 31, 2025), Cosmos Pharmaceutical Corp posted an EPS surprise of -3.05% and a revenue surprise of -74.4%.
When is Cosmos Pharmaceutical Corp (3349) next earnings report?
Cosmos Pharmaceutical Corp is expected to release its next earnings report on August 31, 2025.
What is Cosmos Pharmaceutical Corp (3349) beta (volatility) score?
Cosmos Pharmaceutical Corp has a beta of 0.229, indicating lower volatility than the overall market.